๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The National Impact of Clinical Cooperative Group Trials for Pediatric Cancer

โœ Scribed by Murphy, Sharon B.


Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
207 KB
Volume
24
Category
Article
ISSN
0098-1532

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Childhood cancer in the united states: A
โœ Julie A. Ross; Richard K. Severson; Brad H. Pollock; Leslie L. Robison ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 648 KB

## BACKGROUND. After injuries, cancer is the leading cause of death in children younger than 15 years in the IJnited States. Despite dramatic increases in .?-year survival rates, more than 100,000 person-years of life are lost to childhood cancer each year. 'The exact proportion of pediatric cance

Overview of advanced urothelial cancer t
โœ Robert Dreicer; Bruce Roth; George Wilding ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 83 KB ๐Ÿ‘ 1 views

Advanced transitional cell carcinoma of the urothelium is an aggressive malignancy characterized by a median survival period of less than 1 year. Although this disease is moderately chemotherapy-sensitive, to the authors' knowledge the impact of therapy reported to date on survival has been minimal.

Venous thromboembolism and nonsmall cell
โœ Lisa K. Hicks; Matthew C. Cheung; Keyue Ding; Baktiar Hasan; Lesley Seymour; Aur ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 174 KB ๐Ÿ‘ 2 views

## Abstract ## BACKGROUND: Advanced nonsmall cell lung cancer (NSCLC) is associated with venous thromboembolism (VTE). However, to the authors' knowledge, the incidence of VTE in early NSCLC, predictors of VTE, and the prognostic significance of VTE in NSCLC have not been explored. ## METHODS: I

Clinical trials and drug toxicity in the
โœ Colin B. Begg; Paul P. Carbone ๐Ÿ“‚ Article ๐Ÿ“… 1983 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 520 KB

Nineteen studies of advanced cancer in 8 disease sites have been examined using data from the Eastern Cooperative Oncology Group. The purpose of the investigation was to determine susceptibility of elderly patients (270 years of age) to cancer chemotherapy and to compare the results with correspondi